Clinical Trial Update: The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating different doses of SY-004 in patients with Type 2 Diabetes Mellitus completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SY-004

Snippet

Sponsor: Suzhou Yabao Pharmaceutical R&D Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED